Omnicell Stock Surges After Q1 Earnings Beat and Raised 2026 Profit Outlook

Shares of Omnicell Inc. surged Tuesday, as the medication-management tech firm topped analyst forecasts for both first-quarter earnings and sales, while also boosting its profit target for 2026. The upbeat results fueled momentum for Titan XT, Omnicell’s latest automated dispensing system targeting hospitals and health systems.

Hims & Hers Surges Ahead of Earnings as Omnicell Lags in Healthcare Tech Shakeout

Hims & Hers Surges Ahead of Earnings as Omnicell Lags in Healthcare Tech Shakeout

Hims & Hers Health jumped another 8.9% by 10:25 a.m. EDT on Monday, pushing its winning streak further. Omnicell and Privia Health only managed gains of less than 1%. Telehealth stocks like Hims & Hers remain in focus after Yahoo Finance highlighted the company’s 48.3% surge over the past week ahead of its earnings release set for May 11.